Category

Clinical Trials

AstraZeneca research

New results about AstraZeneca’s Lynparza

October 2, 2021

Positive results from the PROpel …

Clinical trial

SynAct completes patient recruitment to Phase 2a study

September 24, 2021

SynAct Pharma completes patient recruitment …

Anders Månsson

RhoVac completes patient recruitment for phase IIb study

September 22, 2021

RhoVac’s clinical phase IIb study …

cancer

New results from AstraZeneca’s CASPIAN trial

September 20, 2021

Updated results from the Phase …

Göran Forsberg Photo Håkan Sandbring

Cantargia receives approval to start clinical study

September 15, 2021

Cantargia receives regulatory approval to …

New results from AstraZeneca’s POSEIDON trial

September 13, 2021

Positive results from the Phase …

Fredrik Frejd

First patient dosed in Affibody and Inmagene trial

August 31, 2021

The two companies have announced …

Marc Dunoyer

AstraZeneca’s FoCus Phase III trial met primary endpoint

August 31, 2021

Positive results from the trial …

AlzeCure receives phase I trial approval

August 30, 2021

AlzeCure Pharma has received approval …

Göran Forsberg, CEO, Cantargia

Cantargia expands CIRIFOUR trial

August 25, 2021

The company expands the trial …

nerve cells istock

AstraZeneca discontinues CHAMPION-ALS trial

August 23, 2021

Alexion, AstraZeneca Rare Disease, is …

David Rosén

A3P Biomedical announces publication of its STHLM3 MRI trial

August 13, 2021

The company has announced that …

Ultimovacs lab

Further positive trial results from Ultimovacs

August 12, 2021

Ultimovacs has announced positive results …

Martin Welschof

BioInvent enters clinical trial collaboration

August 11, 2021

BioInvent International has entered into …

Jens Bjorheim

First patient enrolled in Ultimovacs trial

August 9, 2021

Ultimovacs has announced that the …

Göran Forsberg, CEO, Cantargia

Cantargia submits clinical trial application

August 5, 2021

Cantargia has announced the submission …

1
2
3
4
5
···
39